J Midwifery Womens Health. 2019 Jan;64(1):36-45. doi: 10.1111/jmwh.12936. Epub 2018 Dec 12.
Although elevated blood glucose is associated with adverse maternal and fetal health outcomes, evidence suggests that women with diabetes may not be receiving comprehensive reproductive health care, including family planning and preconception care. Using a population-based sample, we evaluated the relationship between contraceptive use and biomarker-identified diabetes.
This cross-sectional study used data from 5548 women in the nationally representative National Longitudinal Study of Adolescent to Adult Health (Add Health) from 2007 to 2009. Women were aged 24 to 32 years, sexually active with men, and not pregnant. Hemoglobin A1C identified prediabetes and diabetes from blood specimens. The primary outcome was most effective contraception used in the past year: more effective (sterilization, intrauterine device, implant, combined hormonal methods, or injectable), less effective (condoms, diaphragms, spermicides, natural family planning, or withdrawal), or none. Multinomial regression models were adjusted for race and ethnicity, education, insurance, health care access, and body mass index.
Of the women with diabetes, 37.6% used more effective contraception, 33.6% less effective contraception, and 28.8% none. Women with diabetes had higher odds of using no contraception, rather than more effective contraception, than women with normoglycemia (adjusted odds ratio [aOR], 1.90; 95% CI, 1.25-2.87). Women with diabetes who were undiagnosed had greater odds of using less effective contraception, rather than more effective contraception, compared with those who were diagnosed (aOR 3.39; 95% CI, 1.44-7.96). Contraceptive use did not differ between women with prediabetes and normoglycemia.
Less effective contraceptive methods were commonly used by women with diabetes. Midwives and other women's health care providers can support women with diabetes to reach their pregnancy goals by providing preconception care and family planning.
尽管高血糖与母婴健康不良结局有关,但有证据表明,糖尿病女性可能未接受全面的生殖健康护理,包括计划生育和孕前护理。本研究使用基于人群的样本,评估了避孕措施的使用与生物标志物识别的糖尿病之间的关系。
本横断面研究使用了来自全国代表性的青少年至成年健康纵向研究(Add Health)2007 年至 2009 年 5548 名年龄在 24 至 32 岁、与男性发生性行为且未怀孕的女性的数据。通过血液样本中的糖化血红蛋白(hemoglobin A1C)来识别糖尿病前期和糖尿病。主要结局为过去一年中使用的最有效的避孕措施:更有效的(绝育、宫内节育器、植入物、联合激素方法或注射剂)、效果较差的(避孕套、子宫帽、杀精剂、自然计划生育或体外排精)或没有。多变量回归模型调整了种族和民族、教育、保险、医疗保健机会和体重指数。
在患有糖尿病的女性中,37.6%使用了更有效的避孕措施,33.6%使用了效果较差的避孕措施,28.8%没有使用避孕措施。与血糖正常的女性相比,患有糖尿病的女性更有可能不使用避孕措施,而不是使用更有效的避孕措施(调整后的优势比[aOR],1.90;95%置信区间[CI],1.25-2.87)。与已确诊的糖尿病女性相比,未确诊的糖尿病女性使用效果较差的避孕措施而非更有效的避孕措施的几率更高(aOR 3.39;95%CI,1.44-7.96)。糖尿病前期和血糖正常的女性之间的避孕措施使用没有差异。
患有糖尿病的女性常用效果较差的避孕方法。助产士和其他妇女保健提供者可以通过提供孕前护理和计划生育来支持糖尿病女性实现其妊娠目标。